Abstract

Background: Oral lichen planus has been a mucosal disease of much enigma in speciality of oral medicine and pathology due to it’s intertwined pathophysiology, unidentifiable etiologic factors and absence of suitable management regimen to maintain its remission. Unfolding of pathologic progression in order to identify and further ameliorate the key process or etiology causing it’s manifestation. In the present study we used MMP-9 to get an insight of histopathological feature of both symptomatic and asymptomatic variant of OLP and compare their expression.

Methodology: Study consist of asymptomatic -Group-A (reticular) and symptomatic -group-B (atrophic, erosive) oral lichen planus. Following incisional biopsy paraffinized blocks were prepared. Tissue sections were stained with routine H and E and immunostain MMP-9. Immuonpositive cells were counted in the epithelium and connective tissue at 40X magnification, mean was calculated. Pattern of expression and distribution of MMP-9 was evaluated.

Results: The age group ranged from 23 - 75 years of age with mean age of 45.70 years, with female predominance. The comparison of expression of MMP-9 in group A and B showed a significantly higher expression in Group B than group A. No significant relation of variant of OLP with any gender was detected. No significant difference elicited on noting the pattern of expression in variants of OLP. It was noted that erosive and atrophic forms of OLP has significantly higher MMP-9 expression than reticular OLP.

Conclusion: A statistically significant expression of MMP-9 in symptomatic variant of OLP was seen when compared to asymptomatic type, however no significance was seen in pattern of expression of MMP-9 in different cell layers of both variants of OLP.

Keywords: Atrophic; Erosive; MMP9; Oral Lichen Planus; Reticular; Symptomatic

References

1. Mazzarella N., et al.  “Matrix metalloproteinase gene expression in oral lichen planus: erosive vs. reticular forms”. The Journal of the European Academy of Dermatology and Venereology 20.8 (2006): 953-957.
2. MD Mignogna., et al.  “Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience”. Journal of Oral Oncology 37.3 (2001): 262-267.
3. Paulusová V., et al.  “Expression of matrix metalloproteinase 9 in patients with oral lichen planus”. Acta Medica (Hradec Kralove) 55.1 (2012): 23-26. 
4. Sutinen M., et al.  “Expression of matrixmetalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia,squamous cell carcinoma and lymph node metastasis”. British Journal of Cancer 77 (1998): 2239-2243.
5. Ertugrul AS., et al.  “MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis”. Archives of Oral Biology 58.7 (2013): 843-852. 
6. Li TJ., et al.  “MMP-7 expression in oral lichen planus and oral squamous cell carcinoma”. Asian Pacific Journal of Tropical Medicine 6.8 (2013): 640-643. 
7. Sugerman PB., et al.  “Oral lichen planus”. Clinics in Dermatology 18 (2000): 533-539.
8. Zhou XJ., et al.  “Matrix metalloproteinases and their inhibitors in oral lichen planus”. Journal of Cutaneous Pathology 28.2 (2001): 72-82. 
9. Kubota T., et al.  “Expression of mRNA for matrix metalloproteinases and tissue inhibitors of metalloproteinases in periodontitis-affected human gingival tissue”. Archives of Oral Biology 41.3 (1996): 253-262.
10. Ikebe T., et al.  “Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer”. Clinical and Experimental Metastasis 17.4 (1999): 315-322.
11. Impola U., et al.  “Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer”. The Journal of pathology 202.1 (2004): 14-22.
12. Scully C., et al.  “Update on oral lichen planus: Etiopathogenesis and management”. Critical Reviews in Oral Biology and Medicine 9.1 (1998): 86-122.
13. Eisen D. “The clinical features, malignant transformation and systemic associations of oral lichen planus: a study of 723 patients”. Journal of the American Academy of Dermatology 46.2 (2002): 207-214.
14. Pakfetrat A., et al.  “Oral lichen planus: a retrospective study of 420 Iranian patients”. Medicina Oral Patologia Oral y Cirugia Bucal 14.7 (2009): e315-e318.
15. Roopashree MR., et al.  “Pathogenesis of oral lichen planus - a review”. Journal of Oral Pathology and Medicine 39.10 (2010): 729-734.
16. Ismail SB., et al.  “Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation”. Journal of Oral Science 49.2 (2007): 89-106.
17. GA Rosenberg. “Matrix metalloproteinases in neuroinflammation”. Glia 39.3 (2002): 279-291. 
18. Mona El-Sayed and Howyda Mohamed Ebrahim. “Are tumor necrosis factor-α and matrix metalloproteinase-9 able to induce basal cell degeneration and enhance tissue destruction in cutaneous lichen planus?” Egyptian Journal of Pathology 36.2 (2016): 170-177.
19. Paulusová V., et al.  “Expression of matrix metalloproteinase 9 in patients with oral lichen planus”. Acta Medica (Hradec Kralove) 55.1 (2012): 23-26. 
20. Rubaci AH., et al.  “The roles of matrix metalloproteinases-2, -7, -10 and tissue inhibitor of metalloproteinase-1 in the pathogenesis of oral lichen planus”. Journal of Oral Pathology and Medicine 41.9 (2012): 689-696.
21. Bode W and K Maskos. “Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases”. Journal of Biological Chemistry 384.6 (2003): 863-872. 

Citation

Citation: Venktesh Naikmasur., et al. “Immunoexpression of Matrix-Metalloproteinase-9 in Patients with Asymptomatic and Symptomatic Oral Lichen Planus – A Clinicopathological Study”.Acta Scientific Dental Sciences 4.1 (2020): 104-110.

Copyright

Copyright: © 2020 Venktesh Naikmasur., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.